World Library  
Flag as Inappropriate
Email this Article

Funding bias

Article Id: WHEBN0028248191
Reproduction Date:

Title: Funding bias  
Author: World Heritage Encyclopedia
Language: English
Subject: AllTrials, Conflict of interest, Systematic review, Bias (statistics), Science studies
Publisher: World Heritage Encyclopedia

Funding bias

The phrases funding bias, sponsorship bias, funding outcome bias, or funding publication bias refer to an observed tendency of the conclusion of a scientific research study to support the interests of the study's financial sponsor. This phenomenon is recognized sufficiently that researchers undertake studies to examine bias in past published studies. Funding bias is an instance of experimenter's bias.


Human nature

The psychology text Influence: Science and Practice describes the act of reciprocity as a trait in which a person feels obliged to return favors. This trait is embodied in all human cultures. Human nature may influence even the most ethical researchers to be affected by their sponsors, although they may genuinely deny it.[1]


Scientific malpractice involving shoddy research or data manipulation does occur in rare instances. Often, however, the quality of manufacturers' studies are at least as good as studies that were not funded by a special interest.[2] Therefore, bias usually occurs for other reasons.

Predetermined conclusion

Research results can be selected or discarded to support a predetermined conclusion.[3] The tobacco industry, for example, would publish their own internal research that invariably found minimal adverse health effects of passive smoking.[2]

A company that hires researchers to perform a study may require the researchers to sign a nondisclosure agreement before they are funded, by which researchers waive their right to release any results independently and release them only to the sponsor. The sponsor may fund several studies at the same time, suppressing results found contrary to their business interests while publicizing the results that support their interests. Indeed, a review of pharmaceutical studies revealed that research funded by drug companies was less likely to be published, but the drug-company-funded research that was published was more likely to report outcomes favorable to the sponsor.[4]

A double-blind study with only objective measures is less likely to be biased to support a given conclusion. However, the researchers or the sponsors still have opportunities to skew the results by discarding or ignoring undesirable data, qualitatively characterizing the results, and ultimately deciding whether to publish at all. Also, not all studies are possible to conduct double-blind.

Publication bias

Scientist researcher Anders Sandberg writes that funding bias may be a form of publication bias. Because it is easier to publish positive results than inconclusive or no results, positive results may be correlated with being positive for the sponsor.[5]

Outcome reporting bias is related to publication bias and selection bias, in which multiple outcomes are measured but only the significant outcomes are reported, while insignificant or unfavorable outcomes are ignored.[6]

Selection of subjects or comparators

Selection bias may result in a non-representative population of test subjects on spite of best efforts to obtain a representative sample. Even a double-blind study may be subject to biased selection of dependent variables, population (via inclusion and exclusion criteria), sample size, statistical methods, or inappropriate comparators, any of which can bias the outcome of a study to favor a particular conclusion.[4]


  • A 1996 study on the effects of nicotine on cognitive performance revealed that findings of nicotine or smoking improving performance were more likely to be published by scientists who acknowledged tobacco industry support.[7]
  • A 2003 study of published research on antidepressants found that studies sponsored by manufacturers of selective serotonin reuptake inhibitors (SSRI) and newer antidepressants tended to favor their products over alternatives when compared to non-industry-funded studies. Also, modelling studies funded by industry were more favorable to industry than studies funded by non-industry sponsors.[8] In general, studies funded by drug companies are four times more likely to favor the drug under trial than studies funded by other sponsors.[9]
  • A 2006 review of experimental studies examining the health effects of cell phone use found that studies funded exclusively by industry were least likely to report a statistically significant result.[10]
  • The US Food and Drug Administration (FDA) determined in 2008 that the bisphenol A (BPA) in plastic containers is safe when leeched into food, citing chemical industry studies. Independent research studies reached different conclusions,[11] with over 90 percent of them finding health effects from low doses of BPA.[2]
  • Two opposing commercial sponsors can be at odds with the published findings of research they sponsor. A 2008 Duke University study on rats, funded by the Sugar Association, found adverse effects of consuming the artificial sweetener Splenda. The manufacturer, Johnson & Johnson subsidiary McNeil Nutritionals LLC, responded by sponsoring its own team of experts to refute the study.[12]
  • A 2012 analysis of outcomes of studies pertaining to drugs and medical devices revealed that manufacturing company sponsorship "leads to more favorable results and conclusions than sponsorship by other sources."[13]

See also


  1. ^ Cialdini, Robert B (2008-08-08). Influence: Science and Practice (5th ed). Prentice Hall.  
  2. ^ a b c David Michaels (2008-07-15). "It's Not the Answers That Are Biased, It's the Questions". The Washington Post. 
  3. ^ Wilmshurst, Peter. "Dishonesty in Medical Research". 
  4. ^ a b Joel Lexchin; Bero, LA; Djulbegovic, B; Clark, O; Lisa A Bero, Benjamin Djulbegovic, Otavio Clark (2003-05-31). "Pharmaceutical industry sponsorship and research outcome and quality: systematic review". BMJ 326 (7400): 1167–1170.  
  5. ^  
  6. ^ "Types of Bias". Cochrane Bias Methods Group. 2009-06-19. Retrieved 2010-08-04. 
  7. ^ Christina Turner; George J Spilich (1997). "Research into smoking or nicotine and human cognitive performance: does the source of funding make a difference?". Addiction 92 (11): 1423–1426.  
  8. ^ C. Bruce Baker; Johnsrud, MT; Crismon, ML; Rosenheck, RA; Woods, SW; Michael T. Johnsrud, M. Lynn Crismon, Robert A. Rosenheck, Scott W. Woods (2003). "Quantitative analysis of sponsorship bias in economic studies of antidepressants". The British Journal of Psychiatry 183 (6): 498–506.  
  9. ^ Becker-Brüser W (2010). "Research in the pharmaceutical industry cannot be objective". Z Evid Fortbild Qual Gesundhwes 104 (3): 183–9.  
  10. ^ Anke Huss; Egger, Matthias; Hug, Kerstin; Huwiler-Müntener, Karin; Röösli, Martin; Matthias Egger1, Kerstin Hug, Karin Huwiler-Müntener, Martin Röösli (2006-09-15). "Source of Funding and Results of Studies of Health Effects of Mobile Phone Use: Systematic Review of Experimental Studies". Environmental Health Perspectives 115 (1): 1–4.  
  11. ^ vom Saal FS, Myers JP (2008). "Bisphenol A and Risk of Metabolic Disorders".  
  12. ^ Stephen Daniells (2009-09-25). "Splenda study: Industry and academia respond". 
  13. ^ Lundh, A; Sismondo, S; Lexchin, J; Busuioc, OA; Bero, L (Dec 12, 2012). "Industry sponsorship and research outcome.". The Cochrane database of systematic reviews 12: MR000033.  

External links

This article was sourced from Creative Commons Attribution-ShareAlike License; additional terms may apply. World Heritage Encyclopedia content is assembled from numerous content providers, Open Access Publishing, and in compliance with The Fair Access to Science and Technology Research Act (FASTR), Wikimedia Foundation, Inc., Public Library of Science, The Encyclopedia of Life, Open Book Publishers (OBP), PubMed, U.S. National Library of Medicine, National Center for Biotechnology Information, U.S. National Library of Medicine, National Institutes of Health (NIH), U.S. Department of Health & Human Services, and, which sources content from all federal, state, local, tribal, and territorial government publication portals (.gov, .mil, .edu). Funding for and content contributors is made possible from the U.S. Congress, E-Government Act of 2002.
Crowd sourced content that is contributed to World Heritage Encyclopedia is peer reviewed and edited by our editorial staff to ensure quality scholarly research articles.
By using this site, you agree to the Terms of Use and Privacy Policy. World Heritage Encyclopedia™ is a registered trademark of the World Public Library Association, a non-profit organization.

Copyright © World Library Foundation. All rights reserved. eBooks from Project Gutenberg are sponsored by the World Library Foundation,
a 501c(4) Member's Support Non-Profit Organization, and is NOT affiliated with any governmental agency or department.